Literature DB >> 19236627

A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA(1c)) on exenatide treatment.

A M S Brooks, C A Lissett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19236627     DOI： 10.1111/j.1464-5491.2008.02650.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  5 in total

1.  Bariatric surgery and diabetic retinopathy: a pilot analysis.

Authors:  Lakshminarayanan Varadhan; Tracy Humphreys; Adrian B Walker; Chandra V N Cheruvu; George I Varughese
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 2.  New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy.

Authors:  Mercy Saw; Vincent W Wong; I-Van Ho; Gerald Liew
Journal:  Eye (Lond)       Date:  2019-06-21       Impact factor: 3.775

Review 3.  Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Authors:  Gerhard H Scholz; Holger Fleischmann
Journal:  Ther Adv Endocrinol Metab       Date:  2014-10       Impact factor: 3.565

4.  Monitoring of Diabetic Retinopathy in relation to Bariatric Surgery: a Prospective Observational Study.

Authors:  Troels Brynskov; Caroline Schmidt Laugesen; Annette Lykke Svenningsen; Andrea Karen Floyd; Torben Lykke Sørensen
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

Review 5.  Exenatide Use in the Management of Type 2 Diabetes Mellitus.

Authors:  Angelos Kyriacou; Abu Baker Ahmed
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.